HOW TO CHOOSE the IDEAL RENAL REPLACEMENT THERAPY in SEPSIS?
Autor(a) principal: | |
---|---|
Data de Publicação: | 2013 |
Outros Autores: | |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Institucional da UNIFESP |
Texto Completo: | http://dx.doi.org/10.1097/SHK.0b013e31828fafa6 http://repositorio.unifesp.br/handle/11600/36239 |
Resumo: | Sepsis is the main cause of acute kidney injury (AKI) among individuals hospitalized in intensive care units. Acute kidney injury is an independent risk factor for mortality, and its occurrence increases the complexity and cost of treatment. However, the pathophysiological mechanisms of AKI remain unclear. Hemodynamic, vascular, tubular, cellular, inflammatory, and oxidative processes are involved. Individuals with AKI generally have various comorbidities and are elderly and hypercatabolic and on vasopressors and mechanical ventilation. Dialysis is the main treatment for AKI. Although there is no clear benefit of any specific dialysis modality, these patients are initially instructed to use continuous dialysis methods, especially for the most severe cases with multiple organ system dysfunctions and for those who display signs of hemodynamic instability. Recent studies demonstrate that patients should receive a dialysis dose of at least 25 mL.kg(-1).h(-1). |
id |
UFSP_972439c3afcd80581254377cb38e4ce1 |
---|---|
oai_identifier_str |
oai:repositorio.unifesp.br/:11600/36239 |
network_acronym_str |
UFSP |
network_name_str |
Repositório Institucional da UNIFESP |
repository_id_str |
3465 |
spelling |
HOW TO CHOOSE the IDEAL RENAL REPLACEMENT THERAPY in SEPSIS?Sepsisrenal replacement therapydialysisSepsis is the main cause of acute kidney injury (AKI) among individuals hospitalized in intensive care units. Acute kidney injury is an independent risk factor for mortality, and its occurrence increases the complexity and cost of treatment. However, the pathophysiological mechanisms of AKI remain unclear. Hemodynamic, vascular, tubular, cellular, inflammatory, and oxidative processes are involved. Individuals with AKI generally have various comorbidities and are elderly and hypercatabolic and on vasopressors and mechanical ventilation. Dialysis is the main treatment for AKI. Although there is no clear benefit of any specific dialysis modality, these patients are initially instructed to use continuous dialysis methods, especially for the most severe cases with multiple organ system dysfunctions and for those who display signs of hemodynamic instability. Recent studies demonstrate that patients should receive a dialysis dose of at least 25 mL.kg(-1).h(-1).Universidade Federal de São Paulo UNIFESP, Div Nephrol, São Paulo, BrazilHosp Israelita Albert Einstein, Renal Transplant Unit, São Paulo, BrazilUniversidade Federal de São Paulo UNIFESP, Div Nephrol, São Paulo, BrazilWeb of ScienceLippincott Williams & WilkinsUniversidade Federal de São Paulo (UNIFESP)Hosp Israelita Albert EinsteinFiliponi, Thiago Corsi [UNIFESP]Durao, Marcelino de Souza [UNIFESP]2016-01-24T14:31:37Z2016-01-24T14:31:37Z2013-05-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersion50-53http://dx.doi.org/10.1097/SHK.0b013e31828fafa6Shock. Philadelphia: Lippincott Williams & Wilkins, v. 39, n. 7, p. 50-53, 2013.10.1097/SHK.0b013e31828fafa61073-2322http://repositorio.unifesp.br/handle/11600/36239WOS:000330251000011engShockinfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UNIFESPinstname:Universidade Federal de São Paulo (UNIFESP)instacron:UNIFESP2021-10-05T21:55:27Zoai:repositorio.unifesp.br/:11600/36239Repositório InstitucionalPUBhttp://www.repositorio.unifesp.br/oai/requestbiblioteca.csp@unifesp.bropendoar:34652021-10-05T21:55:27Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)false |
dc.title.none.fl_str_mv |
HOW TO CHOOSE the IDEAL RENAL REPLACEMENT THERAPY in SEPSIS? |
title |
HOW TO CHOOSE the IDEAL RENAL REPLACEMENT THERAPY in SEPSIS? |
spellingShingle |
HOW TO CHOOSE the IDEAL RENAL REPLACEMENT THERAPY in SEPSIS? Filiponi, Thiago Corsi [UNIFESP] Sepsis renal replacement therapy dialysis |
title_short |
HOW TO CHOOSE the IDEAL RENAL REPLACEMENT THERAPY in SEPSIS? |
title_full |
HOW TO CHOOSE the IDEAL RENAL REPLACEMENT THERAPY in SEPSIS? |
title_fullStr |
HOW TO CHOOSE the IDEAL RENAL REPLACEMENT THERAPY in SEPSIS? |
title_full_unstemmed |
HOW TO CHOOSE the IDEAL RENAL REPLACEMENT THERAPY in SEPSIS? |
title_sort |
HOW TO CHOOSE the IDEAL RENAL REPLACEMENT THERAPY in SEPSIS? |
author |
Filiponi, Thiago Corsi [UNIFESP] |
author_facet |
Filiponi, Thiago Corsi [UNIFESP] Durao, Marcelino de Souza [UNIFESP] |
author_role |
author |
author2 |
Durao, Marcelino de Souza [UNIFESP] |
author2_role |
author |
dc.contributor.none.fl_str_mv |
Universidade Federal de São Paulo (UNIFESP) Hosp Israelita Albert Einstein |
dc.contributor.author.fl_str_mv |
Filiponi, Thiago Corsi [UNIFESP] Durao, Marcelino de Souza [UNIFESP] |
dc.subject.por.fl_str_mv |
Sepsis renal replacement therapy dialysis |
topic |
Sepsis renal replacement therapy dialysis |
description |
Sepsis is the main cause of acute kidney injury (AKI) among individuals hospitalized in intensive care units. Acute kidney injury is an independent risk factor for mortality, and its occurrence increases the complexity and cost of treatment. However, the pathophysiological mechanisms of AKI remain unclear. Hemodynamic, vascular, tubular, cellular, inflammatory, and oxidative processes are involved. Individuals with AKI generally have various comorbidities and are elderly and hypercatabolic and on vasopressors and mechanical ventilation. Dialysis is the main treatment for AKI. Although there is no clear benefit of any specific dialysis modality, these patients are initially instructed to use continuous dialysis methods, especially for the most severe cases with multiple organ system dysfunctions and for those who display signs of hemodynamic instability. Recent studies demonstrate that patients should receive a dialysis dose of at least 25 mL.kg(-1).h(-1). |
publishDate |
2013 |
dc.date.none.fl_str_mv |
2013-05-01 2016-01-24T14:31:37Z 2016-01-24T14:31:37Z |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://dx.doi.org/10.1097/SHK.0b013e31828fafa6 Shock. Philadelphia: Lippincott Williams & Wilkins, v. 39, n. 7, p. 50-53, 2013. 10.1097/SHK.0b013e31828fafa6 1073-2322 http://repositorio.unifesp.br/handle/11600/36239 WOS:000330251000011 |
url |
http://dx.doi.org/10.1097/SHK.0b013e31828fafa6 http://repositorio.unifesp.br/handle/11600/36239 |
identifier_str_mv |
Shock. Philadelphia: Lippincott Williams & Wilkins, v. 39, n. 7, p. 50-53, 2013. 10.1097/SHK.0b013e31828fafa6 1073-2322 WOS:000330251000011 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
Shock |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
50-53 |
dc.publisher.none.fl_str_mv |
Lippincott Williams & Wilkins |
publisher.none.fl_str_mv |
Lippincott Williams & Wilkins |
dc.source.none.fl_str_mv |
reponame:Repositório Institucional da UNIFESP instname:Universidade Federal de São Paulo (UNIFESP) instacron:UNIFESP |
instname_str |
Universidade Federal de São Paulo (UNIFESP) |
instacron_str |
UNIFESP |
institution |
UNIFESP |
reponame_str |
Repositório Institucional da UNIFESP |
collection |
Repositório Institucional da UNIFESP |
repository.name.fl_str_mv |
Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP) |
repository.mail.fl_str_mv |
biblioteca.csp@unifesp.br |
_version_ |
1814268266888036352 |